Delivery Order SPE2DP18D0011-SPE2DP19F5674
Award Date 9/6/19
Potential Completion Date 9/4/20
Potential Value $4.3M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $159,762.84 delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc. for the supply of the antiviral medication oseltamivir phosphate. The contract has a firm fixed price and a completion date of September 11, 2018. Genentech USA, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical products, and this order was likely issued against an existing indefinite delivery contract or Federal Supply Schedule to support the...
- This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a biotechnology company and manufacturer of pharmaceuticals. The $115,283.85 firm fixed-price contract is for the antiviral medication oseltamivir phosphate, with a completion date of August 2, 2023. Genentech, which has provided various drugs to federal agencies through indefinite delivery contracts and Federal Supply Schedule agreements, will perform the work at its facility in...
- This is a delivery order awarded to Genentech USA, Inc., a biotechnology company that develops and manufactures pharmaceuticals, by the Defense Logistics Agency Troop Support Medical. The contract is for the antiviral medication oseltamivir phosphate, with a potential value of $468,558.18 and a firm fixed price pricing type. The place of performance is Genentech's facility in South San Francisco, California. The contract does not utilize any set-asides. Genentech has extensive experience...
- The Department of Defense's Defense Logistics Agency Troop Support Medical awarded a $179,992.80 firm fixed-price delivery order to Genentech USA, Inc. to provide the antiviral medication oseltamivir phosphate. Genentech is a foreign-owned, for-profit manufacturer of pharmaceutical products. This order supports maintaining military medical readiness and was placed against an existing indefinite delivery contract. The contract has a completion date of September 12, 2018 and was awarded on...
- This $342,870.90 firm fixed-price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a biotechnology company that manufactures pharmaceuticals. The contract is for the antiviral drug oseltamivir phospha and does not utilize any set-aside designation. Genentech has provided a variety of biologic medicines to government agencies through multiple federal contract vehicles, including the Pharmaceuticals and Drugs Federal Supply Schedule. This...
- This is a $102,842.04 delivery order awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a foreign-owned for-profit biopharmaceutical manufacturer. The order is for the antiviral drug oseltamivir phosphate, with a completion date of September 24, 2019. The contract utilizes a firm-fixed price pricing arrangement and has no set-aside designation. Genentech has previously supplied pharmaceuticals such as Tamiflu and Activase to federal agencies including the...
- This is a firm fixed-price delivery order contract awarded by the Medical Supply Chain, a component of the Department of Defense, to Genentech USA, Inc. The contract has a ceiling value of $353,101.26 and is for the delivery of oseltamivir phosphate, an antiviral medication. The contract was awarded under a larger federal supply schedule contract between Genentech and the Department of Veterans Affairs, valued at $4.9 billion, that enables the company to efficiently provide pharmaceuticals and...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to Genentech USA, Inc. for Tamiflu (oseltamivir) 75 mg capsules with a contract ceiling value of $1,387.32. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 9, 2025, represents a small targeted procurement of antiviral medication. The award was made without a set-aside designation, indicating open competition. Genentech USA, Inc., a foreign-owned...
- This federal contract award, valued at $76,670.01, was issued by the Medical Supply Chain division of the Department of Defense's Defense Logistics Agency (DLA) to Genentech USA, Inc. The award is for the delivery of oseltamivir phosphate, an antiviral medication used to treat and prevent influenza. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. Genentech USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that holds several key contract...
- This federal contract award, SPE2DP16D0008|0021, was made by the Medical Supply Chain division of the Defense agency to Genentech USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals. The $101,188.26 firm-fixed-price delivery order is for the antiviral medication oseltamivir phosphate, with a performance period ending on September 22, 2017. The award is not associated with a set-aside program. Genentech USA, Inc. is a major supplier of pharmaceuticals and biologics to federal...